Capital Analysts LLC’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-91
| Closed | -$2K | – | 1314 |
|
|
2024
Q2 | $2K | Hold |
91
| – | – | ﹤0.01% | 1100 |
|
|
2024
Q1 | $3K | Hold |
91
| – | – | ﹤0.01% | 1009 |
|
|
2023
Q4 | $3K | Hold |
91
| – | – | ﹤0.01% | 985 |
|
|
2023
Q3 | $3K | Sell |
91
-241
| -73% | -$7.95K | ﹤0.01% | 1007 |
|
|
2023
Q2 | $11K | Hold |
332
| – | – | ﹤0.01% | 802 |
|
|
2023
Q1 | $10K | Hold |
332
| – | – | ﹤0.01% | 801 |
|
|
2022
Q4 | $9K | Sell |
332
-701
| -68% | -$19K | ﹤0.01% | 860 |
|
|
2022
Q3 | $34K | Buy |
1,033
+386
| +60% | +$12.7K | ﹤0.01% | 635 |
|
|
2022
Q2 | $20K | Buy |
647
+100
| +18% | +$3.09K | ﹤0.01% | 708 |
|
|
2022
Q1 | $25K | Buy |
547
+2
| +0.4% | +$91 | ﹤0.01% | 650 |
|
|
2021
Q4 | $33K | Sell |
545
-42
| -7% | -$2.54K | ﹤0.01% | 631 |
|
|
2021
Q3 | $44K | Hold |
587
| – | – | ﹤0.01% | 592 |
|
|
2021
Q2 | $54K | Sell |
587
-4,028
| -87% | -$371K | ﹤0.01% | 548 |
|
|
2021
Q1 | $410K | Buy |
4,615
+2,428
| +111% | +$216K | 0.03% | 269 |
|
|
2020
Q4 | $204K | Buy |
+2,187
| New | +$204K | 0.02% | 241 |
|